HPLC-fluorescence determination of EROD activity in wistar rat liver microsomes obtained by two different extraction procedures

Current Pharmaceutical Analysis

Volumn 9, Issue 1, 2013, Pages 43-53

  Belaz, Kátia Roberta A ^a   Oliveira, Regina V ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Calcium aggregation; EROD activity; HPLC fluorescence; Rat liver microsomes; Ultracentrifugation

Indexed keywords

CALCIUM; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; ETHOXYRESORUFIN; ETHOXYRESORUFIN DEETHYLASE; PROTEIN; RESORUFIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BATCH FERMENTATION; BIOTRANSFORMATION; CELL FRACTIONATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG METABOLISM; DRUG STABILITY; ENZYME ACTIVITY; ENZYME METABOLISM; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INCUBATION TIME; LIVER MICROSOME; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PRECIPITATION; RAT; ULTRACENTRIFUGATION;

EID: 84873159442     PISSN: 15734129     EISSN: 1875676X     Source Type: Journal    
DOI: 10.2174/157341213804806034     Document Type: Article

References (51)

1. Sa-ngiamsuntorn, K.; Wongkajornsilp, A.; Kasetsinsombat, K.; Duangsaard, S.; Nuntakarn, L.; Borwornpinyo, S. Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers. Bmc Biotechnology,2011, 11.
2. Gonzalez, F.J. Molecular genetics of the P-450 superfamily. Pharmacology & Therapeutics,1990, 45(1), 1-38.
3. Kresge, N.; Simoni, R.D.; Hill, R.L. The characterization of cytochrome P-450 by Ryo Sato. Journal of Biological Chemistry,2006, 281(20).
4. Sato, R. Cytochrome-P-450 - an inconspicuous start - a citation-classic commentary on the carbon monoxide-binding pigment of liver-microsomes.1. evidence for its hemoprotein nature. Current Contents/Life Sciences,1991, (8), 9-19.
5. Anzenbacher, P.; Anzenbacherova, E. Cytochromes P450 and metabolism of xenobiotics. Cellular and Molecular Life Sciences,2001, 58(5-6), 737-747.
6. Katzung, B.G. Farmacologia Básica e Clínica, 5 ed; Guanabara Koogan Rio de Janeiro, 1994.
7. Tanigushi, C.; Guengerich, P. Metabolismo dos Fármacos. Farmacologia.
8. Nelson, D.R.; Kamataki, T.; Waxman, D.J.; Guengerich, F.P.; Estabrook, R.W.; Feyereisen, R. The P450 superfamily - update on new sequences, gene-mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology,1993, 12(1), 1-51.
9. Lewis, D.F.V. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics - Towards the prediction of human P450 substrate specificity and metabolism. Biochemical Pharmacology,2000, 60(3), 293-306.
10. Lewis, D.F.V, Dickins, M. Substrate SARs in human P450s. Drug Discovery Today,2002, 7(17), 918-925.
11. Weaver, R.J.; Thompson, S.; Smith, G.; Dickins, M.; Elcombe, C.R.; Mayer, R.T. A comparative-study of constitutive and induced alkoxyresorufin o-dealkylation and individual cytochrome-p450 forms in cynomolgus monkey (macaca-fascicularis), human, mouse, rat and hamster liver-microsomes. Biochemical Pharmacology,1994, 47(5), 763-773.
12. Soucek, P. Expression of cytochrome P450 2A6 in Escherichia coli: Purification, spectral and catalytic characterization, and preparation of polyclonal antibodies. Archives of Biochemistry and Biophysics,1999, 370(2), 190-200.
13. Yamazaki, H.; Guo, Z.Y.; Persmark, M.; Mimura, M.; Inoue, K.; Guengerich, F.P. Bufuralol hydroxylation by cytochrome-p450 2d6 and 1a2 enzymes in human liver-microsomes. Molecular Pharmacology,1994, 46(3), 568-577.
14. Amet, Y., Berthou, F., Goasduff, T., Salaun, J.P., Lebreton, L., Menez J.F. Evidence that cytochrome-P450 2e1 is involved in the (omega-1)-hydroxylation of lauric acid in rat-liver microsomes. Biochemical and Biophysical Research Communications,1994, 203(2), 1168-1174.
15. Delaforge M. Importance of metabolism in pharmacological studies: possible in vitro predictability. Nuclear Medicine and Biology,1998, 25(8), 705-709.
16. Ekins, S.; Nikolsky, Y.; Nikolskaya, T. Techniques: Application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends in Pharmacological Sciences,2005, 26(4), 202-209.
17. Testa, B.; Pedretti, A.; Vistoli, G. Foundation review: Reactions and enzymes in the Metabolism of drugs and other Xenobiotics. Drug Discovery Today,2012, 17(11-12), 549-560.
18. Kumar, S.; Sharma, R.; Roychowdhury, A. Modulation of Cytochrome-P450 Inhibition (CYP) in Drug Discovery: A Medicinal Chemistry Perspective. Current Medicinal Chemistry, 2012, 19(21), 3605-3621.
19. Venkatakrishnan, K.; von Moltke, L.L.; Greenblatt, D.J. Human drug metabolism and the cytochromes P450: Application and relevance of in vitro models. Journal of Clinical Pharmacology, 2001, 41(11), 1149-1179.
20. Gungordu, A.; Ozmen, M. Water quality evaluation of two interconnected dam lakes with field-captured and laboratory-acclimated fish, Cyprinus carpio. Environmental Monitoring and Assessment,2012, 184(2), 763-776.
21. Smeets, J.M.W.; Wamsteker, J.; Roth, B.; Everaarts, J.; van den Berg, M. Cytochrome P4501A induction and testosterone hydroxylation in cultured hepatocytes of four fish species. Chemosphere, 2002, 46(2), 163-172.
22. Tateishi, T.; Watanabe, M.; Kumai, T.; Tanaka, M.; Moriya, H.; Yamaguchi, S. CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes. Life Sciences,2000, 67(24), 2913-2920.
23. van Vleet, T.R.; Mace, K.; Coulombe, R.A. Comparative aflatoxin B-1 activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4. Cancer Research,2002, 62(1), 105-112.
24. Verbrugge, L.A.; Giesy, J.P.; Verbrugge, D.A.; Woodin, B.R.; Stegeman, J.J. Catalytic and immunochemical properties of hepatic cytochrome P450 1A in three avian species treated with beta-naphthoflavone or isosafrole. Comparative Biochemistry and Physiology C-Toxicology & Pharmacology,2001, 130(1), 67-83.
25. Hanioka, N.; Tatarazako, N.; Jinno, H.; Arizono, K.; Ando, M. Determination of cytochrome P450 1A activities in mammalian liver microsomes by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B,2000, 744(2), 399-406.
26. Pegolo, S.; Merlanti, R.; Giantin, M.; Dacasto, M.; Montesissa, C.; Capolongo, F. High performance liquid chromatography determination of cytochrome P450 1A and 2C activities in bovine liver microsomes. Veterinary Journal,2010, 183(1), 81-88.
27. Yamazaki, H.; Tanaka, M.; Shimada, T. Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation by human liver cytochrome P450 enzymes. Journal of Chromatography B,1999, 721(1), 13-19.
28. Zamaratskaia, G.; Zlabek, V. EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs. Sensors,2009, 9(3), 2134-2147.
29. Muhammad, H.; Gomes-Carneiro, M.R.; Poca, K.S., De-Oliveira, A.; Afzan, A.; Sulaiman, S.A. Evaluation of the genotoxicity of Orthosiphon stamineus aqueous extract. Journal of Ethnopharmacology, 2011, 133(2), 647-653.
30. Leclercq, I.; Desager, J.P.; Vandenplas, C.; Horsmans, Y. Fast determination of low-level cytochrome P-450 1A1 activity by high-performance liquid chromatography with fluorescence or visible absorbance detection. Journal of Chromatography B-Biomedical Applications,1996, 681(2), 227-232.
31. Piver, B.; Fer, M.; Vitrac, X.; Merillon, J.M.; Dreano, Y.; Berthou, F. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochemical Pharmacology,2004, 68(4), 773-782.
32. Nomeir, A.A.; Ruegg, C.; Shoemaker, M.; Favreau, L.V.; Palamanda, J.R.; Silber, P. Inhibition of CYP3A4 in a rapid microtiter plate assay using recombinant enzyme and in human liver microsomes using conventional substrates. Drug Metabolism and Disposition, 2001, 29(5), 748-753.
33. Girennavar, B.; Poulose, S.M.; Jayaprakasha, G.K.; Bhat, N.G.; Patil, B.S. Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP1B1 isoenzymes. Bioorganic & Medicinal Chemistry, 2006, 14(8), 2606-2612.
34. Rompelberg, C.J.M.; Verhagen, H.; Vanbladeren, P.J. Effects of the naturally-occurring alkenylbenzenes eugenol and trans-anethole on drug-metabolizing-enzymes in the rat-liver. Food and Chemical Toxicology,1993, 31(9), 637-645.
35. Ghosal, A.; Hapangama, N.; Yuan, Y.; Lu, X.W.; Horne, D., Patrick, J.E. Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharmaceutics & Drug Disposition,2003, 24(9), 375-384.
36. Burke, M.D.; Thompson, S.; Elcombe, C.R.; Halpert, J.; Haaparanta, T.; Mayer, R.T. Ethoxyphenoxazones, pentoxyphenoxazones, and benzyloxyphenoxazones and homologs -a series of substrates to distinguish between different induced cytochromes-P-450. Biochemical Pharmacology,1985, 34(18), 3337-3345.
37. Carvalho, R.S.; Friedrich, K.; De-Oliveira, A.; Suarez-Kurtz, G.; Paumgartten, F.J.R. Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in mouse liver. European Journal of Pharmacology,2009, 616(1-3), 265-269.
38. Eriksson, L.C. Preparation of liver-microsomes with high recovery of endoplasmic-reticulum and a low-grade of contamination. Biochimica Et Biophysica Acta,1978, 508(1), 155-164.
39. Gemayel, J.; Geloen, A.; Mion, F. Propofol-induced cytochrome P450 inhibition -An in vitro and in vivo study in rats. Life Sciences,2001, 68(26), 2957-2965.
40. Kennedy, S.W.; Jones, S.P. Simultaneous measurement of cytochrome P4501a catalytic activity and total protein-concentration with a fluorescence plate reader. Analytical Biochemistry, 1994, 222(1), 217-223.
41. Hanioka, N.; Jinno, H.; Tanaka-Kagawa, T.; Nishimura, T.; Ando, M. In vitro metabolism of chlorotriazines: Characterization of simazine, atrazine, and propazine metabolism using liver microsomes from rats treated with various cytochrome P450 inducers. Toxicology and Applied Pharmacology, 1999, 156(3), 195-205.
42. Guengerich, F.P. Studies on activation of a model furan compound - toxicity and covalent binding of 2-(n-ethyl-carbamoy-lhydroxymethyl)furan. Biochemical Pharmacology, 1977, 26(20), 1909-1915.
43. Litterst, C.L.; Mimnaugh, E.G.; Reagan, R.L.; Gram, T.E. Drug-metabolism by microsomes from extrahepatic organs of rat and rabbit prepared by calcium aggregation. Life Sciences, 1975, 17(5), 813-818.
44. Walawalkar, P.S.; Serai, P.S.; Iyer, K.R. Isolation and Catalytic Competence of Different Animal Liver Microsomal Fractions Preapared by Calcium-aggregation Method. Indian Journal of Pharmaceutical Sciences,2006, 68(2), 262-265.
45. Kamath, S.A.; Kummerow, F.A.; Narayan, K.A. Simple procedure for isolation of rat liver microsome. Febs Letters,1971, 17(1), 90-94.
46. 2+ with endoplasmic-reticulum of rat-liver - standardized procedure for isolation of rat-liver microsomes. Analytical Biochemistry,1972, 48(1), 53-56.
47. Bradford, M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Analytical Biochemistry,1976, 72(1-2), 248-254.
48. nd ed. Totowa 2002:15.
49. FDA. Guidance For Industry - Bioanalytical Method Validation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf (Accessed Jan 25, 2007).
50. Chang, T.K.H.; Waxman, D.J. Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate. Cytochrome P450 Protocols. Totawa: Humana Press:103-109.
51. nd ed; Jonhn Wiley and Sons Inc: New York, 1997.